Related Experiment Video
Updated: Sep 25, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
[A case of Parkinsonism possibly associated with long-term methamphetamine use]
Yasuhiro Aso1, Teruaki Masuda2, Kaori Sumi2
1Department of Neurology, Oita Prefectural Hospital.
Abstract:
We report the case of a 60-year-old male who developed parkinsonism following approximately 32 years of methamphetamine (MA) use. The patient had used MA since age 18. He initially noted a mild resting tremor in his right upper limb around age 50, which remained relatively stable for nearly a decade. However, at age 59, gait disturbances emerged and progressed over the following six months. While brain magnetic resonance imaging (MRI) showed no remarkable findings, 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy demonstrated a reduction in the heart-to-mediastinum ratio. Additionally, dopamine transporter single-photon emission computed tomography (DAT-SPECT) revealed decreased uptake in the bilateral striatum. Treatment with levodopa resulted in significant clinical improvement. Given that MA is known to induce neurotoxicity in dopaminergic neurons through mechanisms such as oxidative stress and α-synuclein aggregation, these findings suggest that prolonged MA exposure may trigger a neurodegenerative process leading to parkinsonism with pathophysiological features similar to Parkinson's disease.
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

